nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—CYP2C19—Rosuvastatin—atherosclerosis	0.0787	0.113	CbGbCtD
Metoprolol—CYP2C19—Simvastatin—atherosclerosis	0.0732	0.105	CbGbCtD
Metoprolol—CYP2C19—Lovastatin—atherosclerosis	0.0716	0.103	CbGbCtD
Metoprolol—CYP2D6—Niacin—atherosclerosis	0.0704	0.101	CbGbCtD
Metoprolol—ABCB1—Ezetimibe—atherosclerosis	0.0635	0.0912	CbGbCtD
Metoprolol—ABCB1—Simvastatin—atherosclerosis	0.059	0.0848	CbGbCtD
Metoprolol—ABCB1—Lovastatin—atherosclerosis	0.0578	0.083	CbGbCtD
Metoprolol—ABCB1—Pravastatin—atherosclerosis	0.0578	0.083	CbGbCtD
Metoprolol—CYP2D6—Simvastatin—atherosclerosis	0.0556	0.0799	CbGbCtD
Metoprolol—CYP2D6—Pravastatin—atherosclerosis	0.0544	0.0782	CbGbCtD
Metoprolol—CYP2D6—Lovastatin—atherosclerosis	0.0544	0.0782	CbGbCtD
Metoprolol—Angina pectoris—Pravastatin—atherosclerosis	0.000874	0.00333	CcSEcCtD
Metoprolol—Jaundice—Simvastatin—atherosclerosis	0.000862	0.00329	CcSEcCtD
Metoprolol—Flatulence—Rosuvastatin—atherosclerosis	0.000859	0.00328	CcSEcCtD
Metoprolol—Hepatitis—Lovastatin—atherosclerosis	0.000849	0.00324	CcSEcCtD
Metoprolol—Erectile dysfunction—Niacin—atherosclerosis	0.000839	0.0032	CcSEcCtD
Metoprolol—Hepatitis—Ezetimibe—atherosclerosis	0.000833	0.00317	CcSEcCtD
Metoprolol—Erectile dysfunction—Pravastatin—atherosclerosis	0.000826	0.00315	CcSEcCtD
Metoprolol—Oedema peripheral—Ezetimibe—atherosclerosis	0.00082	0.00313	CcSEcCtD
Metoprolol—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000819	0.00312	CcSEcCtD
Metoprolol—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000818	0.00312	CcSEcCtD
Metoprolol—Weight increased—Pravastatin—atherosclerosis	0.000816	0.00311	CcSEcCtD
Metoprolol—Depression—Pravastatin—atherosclerosis	0.000798	0.00304	CcSEcCtD
Metoprolol—Hepatitis—Simvastatin—atherosclerosis	0.000794	0.00303	CcSEcCtD
Metoprolol—Jaundice—Niacin—atherosclerosis	0.000792	0.00302	CcSEcCtD
Metoprolol—Jaundice—Pravastatin—atherosclerosis	0.00078	0.00297	CcSEcCtD
Metoprolol—Sweating—Niacin—atherosclerosis	0.000779	0.00297	CcSEcCtD
Metoprolol—Angiopathy—Ezetimibe—atherosclerosis	0.000756	0.00288	CcSEcCtD
Metoprolol—Immune system disorder—Ezetimibe—atherosclerosis	0.000752	0.00287	CcSEcCtD
Metoprolol—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000751	0.00286	CcSEcCtD
Metoprolol—Alopecia—Lovastatin—atherosclerosis	0.00075	0.00286	CcSEcCtD
Metoprolol—Arthralgia—Rosuvastatin—atherosclerosis	0.000743	0.00283	CcSEcCtD
Metoprolol—Alopecia—Ezetimibe—atherosclerosis	0.000736	0.00281	CcSEcCtD
Metoprolol—Rhinitis—Niacin—atherosclerosis	0.000731	0.00279	CcSEcCtD
Metoprolol—Mental disorder—Ezetimibe—atherosclerosis	0.00073	0.00278	CcSEcCtD
Metoprolol—Hepatitis—Niacin—atherosclerosis	0.000729	0.00278	CcSEcCtD
Metoprolol—Flatulence—Lovastatin—atherosclerosis	0.000728	0.00278	CcSEcCtD
Metoprolol—Dysgeusia—Lovastatin—atherosclerosis	0.000724	0.00276	CcSEcCtD
Metoprolol—Rhinitis—Pravastatin—atherosclerosis	0.00072	0.00274	CcSEcCtD
Metoprolol—Oedema peripheral—Niacin—atherosclerosis	0.000718	0.00274	CcSEcCtD
Metoprolol—Hepatitis—Pravastatin—atherosclerosis	0.000718	0.00274	CcSEcCtD
Metoprolol—Confusional state—Rosuvastatin—atherosclerosis	0.000718	0.00274	CcSEcCtD
Metoprolol—Flatulence—Ezetimibe—atherosclerosis	0.000714	0.00272	CcSEcCtD
Metoprolol—Muscle spasms—Lovastatin—atherosclerosis	0.000711	0.00271	CcSEcCtD
Metoprolol—Visual impairment—Niacin—atherosclerosis	0.000703	0.00268	CcSEcCtD
Metoprolol—Alopecia—Simvastatin—atherosclerosis	0.000702	0.00268	CcSEcCtD
Metoprolol—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000698	0.00266	CcSEcCtD
Metoprolol—Muscle spasms—Ezetimibe—atherosclerosis	0.000697	0.00266	CcSEcCtD
Metoprolol—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000697	0.00266	CcSEcCtD
Metoprolol—Vision blurred—Lovastatin—atherosclerosis	0.000697	0.00266	CcSEcCtD
Metoprolol—Mental disorder—Simvastatin—atherosclerosis	0.000696	0.00265	CcSEcCtD
Metoprolol—Visual impairment—Pravastatin—atherosclerosis	0.000692	0.00264	CcSEcCtD
Metoprolol—Eye disorder—Niacin—atherosclerosis	0.000682	0.0026	CcSEcCtD
Metoprolol—Flatulence—Simvastatin—atherosclerosis	0.000681	0.0026	CcSEcCtD
Metoprolol—Tinnitus—Niacin—atherosclerosis	0.00068	0.00259	CcSEcCtD
Metoprolol—Dysgeusia—Simvastatin—atherosclerosis	0.000677	0.00258	CcSEcCtD
Metoprolol—Tinnitus—Pravastatin—atherosclerosis	0.000669	0.00255	CcSEcCtD
Metoprolol—Cardiac disorder—Pravastatin—atherosclerosis	0.000666	0.00254	CcSEcCtD
Metoprolol—Muscle spasms—Simvastatin—atherosclerosis	0.000665	0.00253	CcSEcCtD
Metoprolol—Vertigo—Lovastatin—atherosclerosis	0.000664	0.00253	CcSEcCtD
Metoprolol—Angiopathy—Niacin—atherosclerosis	0.000662	0.00252	CcSEcCtD
Metoprolol—Leukopenia—Lovastatin—atherosclerosis	0.000662	0.00252	CcSEcCtD
Metoprolol—Vision blurred—Simvastatin—atherosclerosis	0.000652	0.00248	CcSEcCtD
Metoprolol—Arrhythmia—Niacin—atherosclerosis	0.000651	0.00248	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000649	0.00247	CcSEcCtD
Metoprolol—Alopecia—Niacin—atherosclerosis	0.000644	0.00246	CcSEcCtD
Metoprolol—Insomnia—Rosuvastatin—atherosclerosis	0.000644	0.00245	CcSEcCtD
Metoprolol—Arrhythmia—Pravastatin—atherosclerosis	0.000641	0.00245	CcSEcCtD
Metoprolol—Palpitations—Ezetimibe—atherosclerosis	0.000641	0.00244	CcSEcCtD
Metoprolol—Paraesthesia—Rosuvastatin—atherosclerosis	0.000639	0.00244	CcSEcCtD
Metoprolol—Alopecia—Pravastatin—atherosclerosis	0.000634	0.00242	CcSEcCtD
Metoprolol—Arthralgia—Lovastatin—atherosclerosis	0.000629	0.0024	CcSEcCtD
Metoprolol—Chest pain—Lovastatin—atherosclerosis	0.000629	0.0024	CcSEcCtD
Metoprolol—Anxiety—Lovastatin—atherosclerosis	0.000627	0.00239	CcSEcCtD
Metoprolol—Dyspepsia—Rosuvastatin—atherosclerosis	0.000627	0.00239	CcSEcCtD
Metoprolol—Hypertension—Ezetimibe—atherosclerosis	0.000626	0.00239	CcSEcCtD
Metoprolol—Flatulence—Niacin—atherosclerosis	0.000626	0.00238	CcSEcCtD
Metoprolol—Tension—Niacin—atherosclerosis	0.000623	0.00237	CcSEcCtD
Metoprolol—Vertigo—Simvastatin—atherosclerosis	0.000621	0.00237	CcSEcCtD
Metoprolol—Leukopenia—Simvastatin—atherosclerosis	0.000619	0.00236	CcSEcCtD
Metoprolol—Arthralgia—Ezetimibe—atherosclerosis	0.000617	0.00235	CcSEcCtD
Metoprolol—Chest pain—Ezetimibe—atherosclerosis	0.000617	0.00235	CcSEcCtD
Metoprolol—Nervousness—Niacin—atherosclerosis	0.000617	0.00235	CcSEcCtD
Metoprolol—Flatulence—Pravastatin—atherosclerosis	0.000616	0.00235	CcSEcCtD
Metoprolol—Dry mouth—Lovastatin—atherosclerosis	0.000615	0.00235	CcSEcCtD
Metoprolol—Tension—Pravastatin—atherosclerosis	0.000613	0.00234	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000613	0.00234	CcSEcCtD
Metoprolol—Dysgeusia—Pravastatin—atherosclerosis	0.000612	0.00233	CcSEcCtD
Metoprolol—Muscle spasms—Niacin—atherosclerosis	0.00061	0.00233	CcSEcCtD
Metoprolol—Constipation—Rosuvastatin—atherosclerosis	0.000609	0.00232	CcSEcCtD
Metoprolol—Pain—Rosuvastatin—atherosclerosis	0.000609	0.00232	CcSEcCtD
Metoprolol—Confusional state—Lovastatin—atherosclerosis	0.000608	0.00232	CcSEcCtD
Metoprolol—Nervousness—Pravastatin—atherosclerosis	0.000607	0.00231	CcSEcCtD
Metoprolol—Dry mouth—Ezetimibe—atherosclerosis	0.000604	0.0023	CcSEcCtD
Metoprolol—Muscle spasms—Pravastatin—atherosclerosis	0.000601	0.00229	CcSEcCtD
Metoprolol—Vision blurred—Niacin—atherosclerosis	0.000598	0.00228	CcSEcCtD
Metoprolol—Confusional state—Ezetimibe—atherosclerosis	0.000597	0.00227	CcSEcCtD
Metoprolol—Thrombocytopenia—Lovastatin—atherosclerosis	0.000591	0.00225	CcSEcCtD
Metoprolol—Vision blurred—Pravastatin—atherosclerosis	0.000589	0.00225	CcSEcCtD
Metoprolol—Arthralgia—Simvastatin—atherosclerosis	0.000589	0.00224	CcSEcCtD
Metoprolol—Chest pain—Simvastatin—atherosclerosis	0.000589	0.00224	CcSEcCtD
Metoprolol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000587	0.00224	CcSEcCtD
Metoprolol—Anxiety—Simvastatin—atherosclerosis	0.000587	0.00224	CcSEcCtD
Metoprolol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000582	0.00222	CcSEcCtD
Metoprolol—Nervous system disorder—Ezetimibe—atherosclerosis	0.00058	0.00221	CcSEcCtD
Metoprolol—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000579	0.00221	CcSEcCtD
Metoprolol—Skin disorder—Ezetimibe—atherosclerosis	0.000575	0.00219	CcSEcCtD
Metoprolol—Vertigo—Niacin—atherosclerosis	0.00057	0.00217	CcSEcCtD
Metoprolol—Syncope—Niacin—atherosclerosis	0.000569	0.00217	CcSEcCtD
Metoprolol—Confusional state—Simvastatin—atherosclerosis	0.000569	0.00217	CcSEcCtD
Metoprolol—Leukopenia—Niacin—atherosclerosis	0.000568	0.00217	CcSEcCtD
Metoprolol—Urticaria—Rosuvastatin—atherosclerosis	0.000565	0.00216	CcSEcCtD
Metoprolol—Oedema—Simvastatin—atherosclerosis	0.000564	0.00215	CcSEcCtD
Metoprolol—Abdominal pain—Rosuvastatin—atherosclerosis	0.000563	0.00215	CcSEcCtD
Metoprolol—Vertigo—Pravastatin—atherosclerosis	0.000562	0.00214	CcSEcCtD
Metoprolol—Palpitations—Niacin—atherosclerosis	0.000561	0.00214	CcSEcCtD
Metoprolol—Leukopenia—Pravastatin—atherosclerosis	0.00056	0.00213	CcSEcCtD
Metoprolol—Loss of consciousness—Niacin—atherosclerosis	0.000558	0.00213	CcSEcCtD
Metoprolol—Thrombocytopenia—Simvastatin—atherosclerosis	0.000552	0.00211	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00055	0.0021	CcSEcCtD
Metoprolol—Insomnia—Lovastatin—atherosclerosis	0.000546	0.00208	CcSEcCtD
Metoprolol—Paraesthesia—Lovastatin—atherosclerosis	0.000542	0.00206	CcSEcCtD
Metoprolol—Arthralgia—Niacin—atherosclerosis	0.00054	0.00206	CcSEcCtD
Metoprolol—Hypertension—Pravastatin—atherosclerosis	0.00054	0.00206	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000539	0.00205	CcSEcCtD
Metoprolol—Dyspnoea—Lovastatin—atherosclerosis	0.000538	0.00205	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000537	0.00205	CcSEcCtD
Metoprolol—Insomnia—Ezetimibe—atherosclerosis	0.000535	0.00204	CcSEcCtD
Metoprolol—Arthralgia—Pravastatin—atherosclerosis	0.000532	0.00203	CcSEcCtD
Metoprolol—Chest pain—Pravastatin—atherosclerosis	0.000532	0.00203	CcSEcCtD
Metoprolol—Paraesthesia—Ezetimibe—atherosclerosis	0.000531	0.00203	CcSEcCtD
Metoprolol—Dyspepsia—Lovastatin—atherosclerosis	0.000531	0.00202	CcSEcCtD
Metoprolol—Anxiety—Pravastatin—atherosclerosis	0.00053	0.00202	CcSEcCtD
Metoprolol—Dry mouth—Niacin—atherosclerosis	0.000529	0.00201	CcSEcCtD
Metoprolol—Dyspnoea—Ezetimibe—atherosclerosis	0.000528	0.00201	CcSEcCtD
Metoprolol—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000524	0.002	CcSEcCtD
Metoprolol—Dyspepsia—Ezetimibe—atherosclerosis	0.000521	0.00199	CcSEcCtD
Metoprolol—Fatigue—Lovastatin—atherosclerosis	0.00052	0.00198	CcSEcCtD
Metoprolol—Oedema—Niacin—atherosclerosis	0.000518	0.00198	CcSEcCtD
Metoprolol—Constipation—Lovastatin—atherosclerosis	0.000516	0.00197	CcSEcCtD
Metoprolol—Pain—Lovastatin—atherosclerosis	0.000516	0.00197	CcSEcCtD
Metoprolol—Confusional state—Pravastatin—atherosclerosis	0.000514	0.00196	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000514	0.00196	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000511	0.00195	CcSEcCtD
Metoprolol—Asthenia—Rosuvastatin—atherosclerosis	0.000511	0.00195	CcSEcCtD
Metoprolol—Insomnia—Simvastatin—atherosclerosis	0.00051	0.00195	CcSEcCtD
Metoprolol—Oedema—Pravastatin—atherosclerosis	0.00051	0.00194	CcSEcCtD
Metoprolol—Fatigue—Ezetimibe—atherosclerosis	0.00051	0.00194	CcSEcCtD
Metoprolol—Shock—Niacin—atherosclerosis	0.00051	0.00194	CcSEcCtD
Metoprolol—Paraesthesia—Simvastatin—atherosclerosis	0.000507	0.00193	CcSEcCtD
Metoprolol—Pain—Ezetimibe—atherosclerosis	0.000506	0.00193	CcSEcCtD
Metoprolol—Constipation—Ezetimibe—atherosclerosis	0.000506	0.00193	CcSEcCtD
Metoprolol—Tachycardia—Niacin—atherosclerosis	0.000506	0.00193	CcSEcCtD
Metoprolol—Pruritus—Rosuvastatin—atherosclerosis	0.000504	0.00192	CcSEcCtD
Metoprolol—Skin disorder—Niacin—atherosclerosis	0.000503	0.00192	CcSEcCtD
Metoprolol—Dyspnoea—Simvastatin—atherosclerosis	0.000503	0.00192	CcSEcCtD
Metoprolol—Hyperhidrosis—Niacin—atherosclerosis	0.000501	0.00191	CcSEcCtD
Metoprolol—Thrombocytopenia—Pravastatin—atherosclerosis	0.000499	0.0019	CcSEcCtD
Metoprolol—Feeling abnormal—Lovastatin—atherosclerosis	0.000497	0.00189	CcSEcCtD
Metoprolol—Dyspepsia—Simvastatin—atherosclerosis	0.000497	0.00189	CcSEcCtD
Metoprolol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000493	0.00188	CcSEcCtD
Metoprolol—Hyperhidrosis—Pravastatin—atherosclerosis	0.000493	0.00188	CcSEcCtD
Metoprolol—Feeling abnormal—Ezetimibe—atherosclerosis	0.000488	0.00186	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000487	0.00186	CcSEcCtD
Metoprolol—Diarrhoea—Rosuvastatin—atherosclerosis	0.000487	0.00186	CcSEcCtD
Metoprolol—Fatigue—Simvastatin—atherosclerosis	0.000486	0.00185	CcSEcCtD
Metoprolol—Hypotension—Niacin—atherosclerosis	0.000484	0.00185	CcSEcCtD
Metoprolol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000484	0.00184	CcSEcCtD
Metoprolol—Pain—Simvastatin—atherosclerosis	0.000483	0.00184	CcSEcCtD
Metoprolol—Constipation—Simvastatin—atherosclerosis	0.000483	0.00184	CcSEcCtD
Metoprolol—Urticaria—Lovastatin—atherosclerosis	0.000479	0.00183	CcSEcCtD
Metoprolol—Body temperature increased—Lovastatin—atherosclerosis	0.000477	0.00182	CcSEcCtD
Metoprolol—Abdominal pain—Lovastatin—atherosclerosis	0.000477	0.00182	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000472	0.0018	CcSEcCtD
Metoprolol—Dizziness—Rosuvastatin—atherosclerosis	0.000471	0.00179	CcSEcCtD
Metoprolol—Urticaria—Ezetimibe—atherosclerosis	0.00047	0.00179	CcSEcCtD
Metoprolol—Insomnia—Niacin—atherosclerosis	0.000469	0.00179	CcSEcCtD
Metoprolol—Abdominal pain—Ezetimibe—atherosclerosis	0.000468	0.00178	CcSEcCtD
Metoprolol—Body temperature increased—Ezetimibe—atherosclerosis	0.000468	0.00178	CcSEcCtD
Metoprolol—Paraesthesia—Niacin—atherosclerosis	0.000465	0.00177	CcSEcCtD
Metoprolol—Feeling abnormal—Simvastatin—atherosclerosis	0.000465	0.00177	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000465	0.00177	CcSEcCtD
Metoprolol—Dyspnoea—Niacin—atherosclerosis	0.000462	0.00176	CcSEcCtD
Metoprolol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000461	0.00176	CcSEcCtD
Metoprolol—Insomnia—Pravastatin—atherosclerosis	0.000461	0.00176	CcSEcCtD
Metoprolol—Somnolence—Niacin—atherosclerosis	0.000461	0.00176	CcSEcCtD
Metoprolol—Paraesthesia—Pravastatin—atherosclerosis	0.000458	0.00175	CcSEcCtD
Metoprolol—Dyspepsia—Niacin—atherosclerosis	0.000456	0.00174	CcSEcCtD
Metoprolol—Dyspnoea—Pravastatin—atherosclerosis	0.000455	0.00173	CcSEcCtD
Metoprolol—Dyspepsia—Pravastatin—atherosclerosis	0.000449	0.00171	CcSEcCtD
Metoprolol—Rash—Rosuvastatin—atherosclerosis	0.000449	0.00171	CcSEcCtD
Metoprolol—Dermatitis—Rosuvastatin—atherosclerosis	0.000448	0.00171	CcSEcCtD
Metoprolol—Urticaria—Simvastatin—atherosclerosis	0.000448	0.00171	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Niacin—atherosclerosis	0.000447	0.00171	CcSEcCtD
Metoprolol—Abdominal pain—Simvastatin—atherosclerosis	0.000446	0.0017	CcSEcCtD
Metoprolol—Body temperature increased—Simvastatin—atherosclerosis	0.000446	0.0017	CcSEcCtD
Metoprolol—Headache—Rosuvastatin—atherosclerosis	0.000446	0.0017	CcSEcCtD
Metoprolol—Hypersensitivity—Lovastatin—atherosclerosis	0.000444	0.00169	CcSEcCtD
Metoprolol—Pain—Niacin—atherosclerosis	0.000443	0.00169	CcSEcCtD
Metoprolol—Fatigue—Pravastatin—atherosclerosis	0.00044	0.00168	CcSEcCtD
Metoprolol—Pain—Pravastatin—atherosclerosis	0.000436	0.00166	CcSEcCtD
Metoprolol—Constipation—Pravastatin—atherosclerosis	0.000436	0.00166	CcSEcCtD
Metoprolol—Hypersensitivity—Ezetimibe—atherosclerosis	0.000436	0.00166	CcSEcCtD
Metoprolol—Asthenia—Lovastatin—atherosclerosis	0.000433	0.00165	CcSEcCtD
Metoprolol—Pruritus—Lovastatin—atherosclerosis	0.000427	0.00163	CcSEcCtD
Metoprolol—Asthenia—Ezetimibe—atherosclerosis	0.000425	0.00162	CcSEcCtD
Metoprolol—Gastrointestinal pain—Niacin—atherosclerosis	0.000424	0.00162	CcSEcCtD
Metoprolol—Nausea—Rosuvastatin—atherosclerosis	0.000423	0.00161	CcSEcCtD
Metoprolol—Feeling abnormal—Pravastatin—atherosclerosis	0.00042	0.0016	CcSEcCtD
Metoprolol—Pruritus—Ezetimibe—atherosclerosis	0.000419	0.0016	CcSEcCtD
Metoprolol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000417	0.00159	CcSEcCtD
Metoprolol—Hypersensitivity—Simvastatin—atherosclerosis	0.000416	0.00158	CcSEcCtD
Metoprolol—Diarrhoea—Lovastatin—atherosclerosis	0.000413	0.00157	CcSEcCtD
Metoprolol—Urticaria—Niacin—atherosclerosis	0.000412	0.00157	CcSEcCtD
Metoprolol—Body temperature increased—Niacin—atherosclerosis	0.00041	0.00156	CcSEcCtD
Metoprolol—Abdominal pain—Niacin—atherosclerosis	0.00041	0.00156	CcSEcCtD
Metoprolol—Urticaria—Pravastatin—atherosclerosis	0.000405	0.00154	CcSEcCtD
Metoprolol—Asthenia—Simvastatin—atherosclerosis	0.000405	0.00154	CcSEcCtD
Metoprolol—Diarrhoea—Ezetimibe—atherosclerosis	0.000405	0.00154	CcSEcCtD
Metoprolol—Abdominal pain—Pravastatin—atherosclerosis	0.000403	0.00154	CcSEcCtD
Metoprolol—Body temperature increased—Pravastatin—atherosclerosis	0.000403	0.00154	CcSEcCtD
Metoprolol—Pruritus—Simvastatin—atherosclerosis	0.000399	0.00152	CcSEcCtD
Metoprolol—Dizziness—Lovastatin—atherosclerosis	0.000399	0.00152	CcSEcCtD
Metoprolol—Dizziness—Ezetimibe—atherosclerosis	0.000391	0.00149	CcSEcCtD
Metoprolol—Diarrhoea—Simvastatin—atherosclerosis	0.000386	0.00147	CcSEcCtD
Metoprolol—Vomiting—Lovastatin—atherosclerosis	0.000384	0.00146	CcSEcCtD
Metoprolol—Hypersensitivity—Niacin—atherosclerosis	0.000382	0.00146	CcSEcCtD
Metoprolol—Rash—Lovastatin—atherosclerosis	0.00038	0.00145	CcSEcCtD
Metoprolol—Dermatitis—Lovastatin—atherosclerosis	0.00038	0.00145	CcSEcCtD
Metoprolol—Headache—Lovastatin—atherosclerosis	0.000378	0.00144	CcSEcCtD
Metoprolol—Vomiting—Ezetimibe—atherosclerosis	0.000376	0.00143	CcSEcCtD
Metoprolol—Hypersensitivity—Pravastatin—atherosclerosis	0.000376	0.00143	CcSEcCtD
Metoprolol—Dizziness—Simvastatin—atherosclerosis	0.000373	0.00142	CcSEcCtD
Metoprolol—Rash—Ezetimibe—atherosclerosis	0.000373	0.00142	CcSEcCtD
Metoprolol—Dermatitis—Ezetimibe—atherosclerosis	0.000373	0.00142	CcSEcCtD
Metoprolol—Asthenia—Niacin—atherosclerosis	0.000372	0.00142	CcSEcCtD
Metoprolol—Headache—Ezetimibe—atherosclerosis	0.000371	0.00141	CcSEcCtD
Metoprolol—Pruritus—Niacin—atherosclerosis	0.000367	0.0014	CcSEcCtD
Metoprolol—Asthenia—Pravastatin—atherosclerosis	0.000366	0.0014	CcSEcCtD
Metoprolol—Pruritus—Pravastatin—atherosclerosis	0.000361	0.00138	CcSEcCtD
Metoprolol—Vomiting—Simvastatin—atherosclerosis	0.000359	0.00137	CcSEcCtD
Metoprolol—Nausea—Lovastatin—atherosclerosis	0.000358	0.00137	CcSEcCtD
Metoprolol—Rash—Simvastatin—atherosclerosis	0.000356	0.00136	CcSEcCtD
Metoprolol—Dermatitis—Simvastatin—atherosclerosis	0.000355	0.00135	CcSEcCtD
Metoprolol—Diarrhoea—Niacin—atherosclerosis	0.000354	0.00135	CcSEcCtD
Metoprolol—Headache—Simvastatin—atherosclerosis	0.000353	0.00135	CcSEcCtD
Metoprolol—Nausea—Ezetimibe—atherosclerosis	0.000351	0.00134	CcSEcCtD
Metoprolol—Diarrhoea—Pravastatin—atherosclerosis	0.000349	0.00133	CcSEcCtD
Metoprolol—Dizziness—Niacin—atherosclerosis	0.000343	0.00131	CcSEcCtD
Metoprolol—Dizziness—Pravastatin—atherosclerosis	0.000337	0.00129	CcSEcCtD
Metoprolol—Nausea—Simvastatin—atherosclerosis	0.000335	0.00128	CcSEcCtD
Metoprolol—Vomiting—Niacin—atherosclerosis	0.000329	0.00126	CcSEcCtD
Metoprolol—Rash—Niacin—atherosclerosis	0.000327	0.00125	CcSEcCtD
Metoprolol—Dermatitis—Niacin—atherosclerosis	0.000326	0.00124	CcSEcCtD
Metoprolol—Headache—Niacin—atherosclerosis	0.000325	0.00124	CcSEcCtD
Metoprolol—Vomiting—Pravastatin—atherosclerosis	0.000324	0.00124	CcSEcCtD
Metoprolol—Rash—Pravastatin—atherosclerosis	0.000322	0.00123	CcSEcCtD
Metoprolol—Dermatitis—Pravastatin—atherosclerosis	0.000321	0.00122	CcSEcCtD
Metoprolol—Headache—Pravastatin—atherosclerosis	0.00032	0.00122	CcSEcCtD
Metoprolol—Nausea—Niacin—atherosclerosis	0.000308	0.00117	CcSEcCtD
Metoprolol—Nausea—Pravastatin—atherosclerosis	0.000303	0.00116	CcSEcCtD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	2.01e-05	0.000489	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	2e-05	0.000485	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	2e-05	0.000485	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.99e-05	0.000484	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	1.99e-05	0.000483	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	1.99e-05	0.000483	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	1.99e-05	0.000483	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	1.99e-05	0.000483	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.98e-05	0.000482	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.98e-05	0.000481	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	1.97e-05	0.000478	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	1.97e-05	0.000477	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOA2—atherosclerosis	1.97e-05	0.000477	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALOX15—atherosclerosis	1.97e-05	0.000477	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	1.97e-05	0.000477	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	1.94e-05	0.000472	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	1.94e-05	0.000472	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	1.94e-05	0.000472	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ABCG5—atherosclerosis	1.94e-05	0.000471	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.94e-05	0.000471	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.92e-05	0.000466	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.92e-05	0.000466	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALOX15—atherosclerosis	1.92e-05	0.000466	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOA2—atherosclerosis	1.92e-05	0.000466	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	1.91e-05	0.000464	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.91e-05	0.000463	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ABCG5—atherosclerosis	1.89e-05	0.00046	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—LPA—atherosclerosis	1.87e-05	0.000455	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	1.87e-05	0.000454	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.85e-05	0.000449	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—LPA—atherosclerosis	1.83e-05	0.000444	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	1.83e-05	0.000444	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—BGN—atherosclerosis	1.82e-05	0.000441	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOA2—atherosclerosis	1.81e-05	0.000439	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.81e-05	0.000439	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.81e-05	0.000439	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.81e-05	0.000439	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.8e-05	0.000438	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOA5—atherosclerosis	1.8e-05	0.000437	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	1.79e-05	0.000434	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.79e-05	0.000434	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—HMOX1—atherosclerosis	1.78e-05	0.000431	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—BGN—atherosclerosis	1.77e-05	0.00043	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOA5—atherosclerosis	1.75e-05	0.000426	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.75e-05	0.000424	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	1.74e-05	0.000424	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	1.73e-05	0.000421	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.73e-05	0.00042	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LPA—atherosclerosis	1.72e-05	0.000419	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.71e-05	0.000415	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	1.71e-05	0.000415	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	1.7e-05	0.000413	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOB—atherosclerosis	1.7e-05	0.000413	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	1.7e-05	0.000412	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.69e-05	0.000412	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.69e-05	0.000411	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	1.69e-05	0.000411	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.69e-05	0.00041	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.67e-05	0.000406	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.67e-05	0.000406	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—BGN—atherosclerosis	1.67e-05	0.000406	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	1.66e-05	0.000404	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTM1—atherosclerosis	1.65e-05	0.000402	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	1.65e-05	0.000402	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOA5—atherosclerosis	1.65e-05	0.000401	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALOX5—atherosclerosis	1.63e-05	0.000396	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—LPL—atherosclerosis	1.62e-05	0.000394	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	1.6e-05	0.000389	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.59e-05	0.000386	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GPX1—atherosclerosis	1.58e-05	0.000385	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.57e-05	0.000381	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	1.57e-05	0.00038	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	1.55e-05	0.000375	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.54e-05	0.000375	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CD36—atherosclerosis	1.54e-05	0.000375	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	1.54e-05	0.000374	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.54e-05	0.000373	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	1.51e-05	0.000367	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	1.51e-05	0.000366	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.5e-05	0.000364	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	1.49e-05	0.000363	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.49e-05	0.000362	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—LIPC—atherosclerosis	1.49e-05	0.000362	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	1.48e-05	0.00036	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOC3—atherosclerosis	1.48e-05	0.000359	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—LDLR—atherosclerosis	1.47e-05	0.000357	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	1.47e-05	0.000357	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NAMPT—atherosclerosis	1.46e-05	0.000355	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MTHFR—atherosclerosis	1.46e-05	0.000355	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	1.46e-05	0.000355	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	1.46e-05	0.000354	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—LIPC—atherosclerosis	1.45e-05	0.000353	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	1.45e-05	0.000352	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOC3—atherosclerosis	1.44e-05	0.000351	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	1.44e-05	0.000349	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CETP—atherosclerosis	1.44e-05	0.000349	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—LDLR—atherosclerosis	1.44e-05	0.000349	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPARA—atherosclerosis	1.43e-05	0.000348	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	1.43e-05	0.000347	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	1.43e-05	0.000347	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CETP—atherosclerosis	1.4e-05	0.000341	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	1.4e-05	0.000339	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AGT—atherosclerosis	1.39e-05	0.000337	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	1.39e-05	0.000337	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.38e-05	0.000335	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.38e-05	0.000334	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.38e-05	0.000334	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LIPC—atherosclerosis	1.37e-05	0.000333	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOC3—atherosclerosis	1.36e-05	0.000331	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOE—atherosclerosis	1.36e-05	0.000331	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	1.36e-05	0.00033	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LDLR—atherosclerosis	1.35e-05	0.000329	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	1.35e-05	0.000328	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CAV1—atherosclerosis	1.35e-05	0.000328	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOA1—atherosclerosis	1.35e-05	0.000327	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	1.35e-05	0.000327	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SCARB1—atherosclerosis	1.34e-05	0.000326	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.34e-05	0.000325	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	1.32e-05	0.000321	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CETP—atherosclerosis	1.32e-05	0.000321	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	1.32e-05	0.00032	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.3e-05	0.000316	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HMGCR—atherosclerosis	1.27e-05	0.000308	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.27e-05	0.000307	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	1.25e-05	0.000304	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.24e-05	0.000302	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CG—atherosclerosis	1.23e-05	0.000298	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	1.22e-05	0.000297	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	1.22e-05	0.000296	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	1.2e-05	0.00029	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	1.2e-05	0.00029	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.2e-05	0.00029	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	1.19e-05	0.00029	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPARG—atherosclerosis	1.19e-05	0.000288	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	1.18e-05	0.000288	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	1.18e-05	0.000287	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.17e-05	0.000285	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	1.17e-05	0.000284	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	1.17e-05	0.000284	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—INS—atherosclerosis	1.16e-05	0.000282	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	1.16e-05	0.000282	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.16e-05	0.000281	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	1.16e-05	0.000281	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	1.14e-05	0.000277	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ABCA1—atherosclerosis	1.13e-05	0.000275	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—F2—atherosclerosis	1.13e-05	0.000274	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	1.12e-05	0.000271	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—F2—atherosclerosis	1.1e-05	0.000268	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	1.08e-05	0.000262	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ALB—atherosclerosis	1.07e-05	0.000259	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.07e-05	0.000259	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	1.06e-05	0.000256	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	1.03e-05	0.000251	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—INS—atherosclerosis	1.02e-05	0.000248	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—NOS3—atherosclerosis	1.02e-05	0.000248	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	1.01e-05	0.000246	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	1.01e-05	0.000244	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—INS—atherosclerosis	9.99e-06	0.000243	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HMOX1—atherosclerosis	9.94e-06	0.000241	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	9.88e-06	0.00024	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	9.83e-06	0.000239	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HMOX1—atherosclerosis	9.7e-06	0.000236	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	9.67e-06	0.000235	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOB—atherosclerosis	9.52e-06	0.000231	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	9.38e-06	0.000228	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS2—atherosclerosis	9.33e-06	0.000226	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOB—atherosclerosis	9.29e-06	0.000226	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTM1—atherosclerosis	9.26e-06	0.000225	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	9.18e-06	0.000223	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HMOX1—atherosclerosis	9.14e-06	0.000222	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—LPL—atherosclerosis	9.09e-06	0.000221	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTM1—atherosclerosis	9.04e-06	0.000219	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	8.96e-06	0.000218	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—LPL—atherosclerosis	8.87e-06	0.000215	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GPX1—atherosclerosis	8.87e-06	0.000215	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	8.76e-06	0.000213	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOB—atherosclerosis	8.75e-06	0.000213	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GPX1—atherosclerosis	8.65e-06	0.00021	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CD36—atherosclerosis	8.64e-06	0.00021	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTM1—atherosclerosis	8.52e-06	0.000207	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CD36—atherosclerosis	8.43e-06	0.000205	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LPL—atherosclerosis	8.36e-06	0.000203	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MTHFR—atherosclerosis	8.18e-06	0.000199	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GPX1—atherosclerosis	8.16e-06	0.000198	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARA—atherosclerosis	8.03e-06	0.000195	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MTHFR—atherosclerosis	7.99e-06	0.000194	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	7.95e-06	0.000193	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CD36—atherosclerosis	7.94e-06	0.000193	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARA—atherosclerosis	7.84e-06	0.00019	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AGT—atherosclerosis	7.77e-06	0.000189	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	7.77e-06	0.000189	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	7.68e-06	0.000186	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOE—atherosclerosis	7.62e-06	0.000185	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AGT—atherosclerosis	7.59e-06	0.000184	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	7.56e-06	0.000184	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CAV1—atherosclerosis	7.55e-06	0.000183	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOA1—atherosclerosis	7.53e-06	0.000183	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MTHFR—atherosclerosis	7.53e-06	0.000183	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	7.51e-06	0.000182	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOE—atherosclerosis	7.44e-06	0.000181	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	7.39e-06	0.00018	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARA—atherosclerosis	7.38e-06	0.000179	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CAV1—atherosclerosis	7.37e-06	0.000179	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOA1—atherosclerosis	7.35e-06	0.000179	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	7.19e-06	0.000175	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AGT—atherosclerosis	7.15e-06	0.000174	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	7.11e-06	0.000173	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	7.03e-06	0.000171	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOE—atherosclerosis	7.01e-06	0.00017	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	6.99e-06	0.00017	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	6.97e-06	0.000169	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	6.96e-06	0.000169	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CAV1—atherosclerosis	6.94e-06	0.000169	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOA1—atherosclerosis	6.93e-06	0.000168	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CG—atherosclerosis	6.87e-06	0.000167	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	6.84e-06	0.000166	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	6.82e-06	0.000166	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CG—atherosclerosis	6.71e-06	0.000163	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARG—atherosclerosis	6.64e-06	0.000161	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—INS—atherosclerosis	6.51e-06	0.000158	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARG—atherosclerosis	6.48e-06	0.000157	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	6.45e-06	0.000157	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	6.39e-06	0.000155	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—INS—atherosclerosis	6.35e-06	0.000154	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CG—atherosclerosis	6.32e-06	0.000154	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	6.31e-06	0.000153	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	6.25e-06	0.000152	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	6.11e-06	0.000148	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARG—atherosclerosis	6.1e-06	0.000148	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—INS—atherosclerosis	5.99e-06	0.000145	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	5.97e-06	0.000145	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALB—atherosclerosis	5.97e-06	0.000145	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	5.92e-06	0.000144	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALB—atherosclerosis	5.82e-06	0.000141	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	5.8e-06	0.000141	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NOS3—atherosclerosis	5.71e-06	0.000139	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NOS3—atherosclerosis	5.57e-06	0.000135	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALB—atherosclerosis	5.49e-06	0.000133	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NOS3—atherosclerosis	5.25e-06	0.000127	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS2—atherosclerosis	5.22e-06	0.000127	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS2—atherosclerosis	5.09e-06	0.000124	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS2—atherosclerosis	4.8e-06	0.000117	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AKT1—atherosclerosis	4.69e-06	0.000114	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	4.46e-06	0.000108	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	4.37e-06	0.000106	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	4.12e-06	0.0001	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	4.03e-06	9.78e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKT1—atherosclerosis	2.62e-06	6.37e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKT1—atherosclerosis	2.56e-06	6.22e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKT1—atherosclerosis	2.41e-06	5.86e-05	CbGpPWpGaD
